Lichenoid Eruption During Chronic Hepatic C Treatment with Interferon-Alpha 2 a Plus Ribavirin

被引：0
作者：
Sahnoun, R. [1 ]
Kastalli, S. [1 ]
Charfi, O. [1 ]
Zaiem, A. [1 ]
Lakhal, M. [1 ]
Daghfous, R. [1 ]
El Aidli, S. [1 ]
机构：
[1] Natl Ctr Pharmacovigilance, Tunis, Tunisia
来源：
DRUG SAFETY | 2013年 / 36卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：869 / 869
页数：1
相关论文
共 50 条
[21]   Outcomes of treatment of hepatitis C cirrhosis with pegylated interferon-alpha and ribavirin [J].
Kong, J. ;
Kontorinis, N. ;
Studd, C. ;
Tarquinio, L. ;
Nazareth, S. ;
McInerney, M. ;
Cheng, W. .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 :A293-A294
[22]   Development of myasthenia gravis during treatment of chronic hepatitis C with interferon-alpha and ribavirin. A case report. [J].
Weegink, CJ ;
Molenaar, DS ;
Chamuleau, RA ;
Reesink, HW .
HEPATOLOGY, 2000, 32 (04) :565A-565A
[23]   A Comparison of Interferon alpha-2a Plus Ribavirin Combination Therapy with Peginterferon alpha-2a Plus Ribavirin Combination Therapy for the Treatment of Chronic Hepatitis C [J].
Demiraslan, Hayati ;
Aygen, Bilgehan ;
Yildiz, Orhan ;
Soyuer, Isin ;
Gokahmetoglu, Selma .
VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, 2008, 13 (01) :12-22
[24]   Alterations of soluble transferrin receptor level in children with chronic hepatitis C during treatment with recombinant interferon-alpha and ribavirin [J].
Mozer-Lisewska, I ;
Mania, A ;
Kowala-Piaskowska, A ;
Figlerowicz, M ;
Sluzewski, W .
HEPATOLOGY RESEARCH, 2005, 33 (01) :19-23
[25]   Efficacy and tolerability of pegylated interferon alpha-2a plus ribavirin versus pegylated interferon alpha-2b plus ribavirin, in treatment naive chronic hepatitis C patients [J].
Lee, S. Y. ;
Lee, S. ;
Ko, K. S. ;
Kim, I. H. ;
Kim, S. H. ;
Kim, S. W. ;
Lee, S. O. ;
Lee, S. T. ;
Kim, D. G. ;
Choi, C. S. ;
Cho, E. Y. ;
Kim, H. C. .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 :A176-A176
[26]   Comparison of Sofosbuvir Plus Ribavirin Treatment with Pegylated Interferon Plus Ribavirin Treatment for Chronic Hepatitis C Genotype 2 [J].
Seo, Kayo ;
Kim, Soo Ki ;
Kim, Soo Ryang ;
Ohtani, Aya ;
Kobayashi, Mana ;
Kato, Airi ;
Morimoto, Eri ;
Saijo, Yuka ;
Kim, Ke Ih ;
Imoto, Susumu ;
Kim, Chi Wan ;
Yano, Yoshihiko ;
Kudo, Masatoshi ;
Hayashi, Yoshitake .
DIGESTIVE DISEASES, 2017, 35 (06) :541-547
[27]   Virological and biochemical response to combined interferon-alpha plus ribavirin therapy in patients with chronic hepatitis C. [J].
Kessler, HH ;
Pierer, K ;
Fickert, P ;
Stauber, RE .
GASTROENTEROLOGY, 1997, 112 (04) :A1300-A1300
[28]   Two patients with chronic psychotic disorders who completed interferon-alpha plus ribavirin therapy for hepatitis C [J].
Drozdz, W. ;
Kozielewicz, D. ;
Dybowska, D. ;
Halota, W. ;
Borkowska, A. .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 :S490-S491
[29]   Treatment with interferon-alpha2a alone or interferon-alpha2a plus ribavirin in patients with chronic hepatitis C previously treated with interferon-alpha2a [J].
Bell, H ;
Hellum, K ;
Harthug, S ;
Myrvang, B ;
Ritland, S ;
Mæland, A ;
von der Lippe, B ;
Bjoro, K ;
Skaug, K ;
Gutigard, BG ;
Raknerud, N ;
Simmonds, P .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1999, 34 (02) :194-198
[30]   TREATMENT OF CHRONIC HEPATITIS-C WITH INTERFERON-ALPHA [J].
MARCELLIN, P ;
BENHAMOU, JP .
GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 1991, 15 (8-9) :613-614
12345